Novadaq Technologies Inc., a leading developer and provider of clinically relevant fluorescence imaging solutions, has recently received the United States Patent No. 8,892,190 entitled “Method and Apparatus for Performing Intra-Operative Angiography.” Novadaq’s most recent US Patent adds to the ever-increasing patent portfolio surrounding its SPY fluorescence imaging technology.

“Novadaq is always growing its intellectual property portfolio and this patent further strengthens the company’s proprietary position with respect to our SPY technology,” commented Dr. Arun Menawat, Novadaq’s President and CEO. “With the growth of our portfolio running alongside the continued development of our market-leading technology, Novadaq is making it increasingly difficult for others to exploit Novadaq’s proprietary technology without infringing our IP position.”

Dr Menawat continued, “While there are many aspects to our IP strategy, we are pleased that this patent is clearly relevant to devices using ICG-based fluorescence techniques to image vasculature in clinical specialties such as plastic and reconstructive surgery, gastro-intestinal surgery, cardiac surgery, and organ transplant surgery, among others.”

Enabling medical professionals with clinically relevant, point-of-care imaging solutions to enhance the lives of patients and their caregivers, while reducing health care costs, is Novadaq’s global mission.